U.S. Physical Therapy, Inc. (USPH) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by U.S. Physical Therapy, Inc. on February 25, 2026. The filing primarily addresses executive leadership changes, the declaration of a quarterly dividend, and references the release of financial results for the three and twelve months ended December 31, 2025.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing results for the three and twelve months ended December 31, 2025. However, the text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial metric disclosed in this document is the declaration of a quarterly dividend of $0.46 per share.
Material Changes
- Executive Departure: Carey Hendrickson, Chief Financial Officer, resigned effective April 24, 2026, to pursue another CFO position. The resignation is not related to any disagreement regarding accounting practices or financial reporting.
- Interim Appointment: Jason Curtis, Senior Vice President of Finance and Accounting, has been appointed as Interim Chief Financial Officer pending a search for a permanent successor.
- Dividend Declaration: The Board declared a quarterly dividend of $0.46 per share, payable on April 10, 2026, to shareholders of record on March 13, 2026.
Guidance, Outlook, and Risks
The filing does not contain specific management guidance, outlook, or risk factors beyond the standard disclosure regarding the CFO transition. The company is conducting a comprehensive search for a permanent CFO. The financial results for the period ended December 31, 2025, are detailed in the attached press release but are not summarized within the body of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for the quarter and year ended December 31, 2025.
- Monitor the timeline for the appointment of a permanent Chief Financial Officer following the interim appointment of Jason Curtis.
- Confirm the record date (March 13, 2026) and payment date (April 10, 2026) for the $0.46 per share dividend.
- Verify that the CFO departure was not precipitated by any undisclosed accounting irregularities, as stated in the filing.